Cochlear Limited (FRA:OC5)

Market Cap	3.80B -57.3%
Revenue (ttm)	1.33B +1.3%
Net Income	196.17M -6.8%
EPS	2.99 -6.6%
Shares Out	n/a
PE Ratio	19.35
Forward PE	17.56
Dividend	2.53 (2.47%)
Ex-Dividend Date	Mar 19, 2026

Volume	n/a
Average Volume	37
Open	59.34
Previous Close	58.42
Day's Range	59.34 - 59.34
52-Week Range	58.42 - 179.94
Beta	n/a
RSI	11.39
Earnings Date	Aug 18, 2026

About Cochlear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1981
• Employees: 5,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC5

Financial Performance

In fiscal year 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.

Financial numbers in AUD